Gonadotropin type and AFC-adjusted follicular recruitment and oocyte yield in 4525 antagonist cycles
Reproductive BioMedicine Online · 2026
DOI: 10.1016/j.rbmo.2026.105478 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproductive BioMedicine Online, 2026. Verfasst von Lien Dhaenens und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Reproductive Medicine, Ghent University Hospital, Corneel Heymanslaan 10, 9000 Gent, Belgium; Department of Human Structure and Repair,…. Hauptthemen laut MEDLINE: Ovarian Follicle, Ovulation Induction, Follicle Stimulating Hormone, Human, Menotropins.
Abstract (Originalsprache)
RESEARCH QUESTION: Do FSH types (recombinant FSH [rFSH] versus highly purified human menopausal gonadotrophin (HP-HMG) versus corifollitropin alfa (CFA) differ in the efficiency of ovarian response, as assessed by follicular output rate (FORT) and follicle-to oocyte index (FOI)? DESIGN: Retrospective cohort study analysing 4525 antagonist IVF and intracytoplasmic sperm injection cycles using CFA (n = 728), rFSH (n = 1848) or HP-HMG (n = 1949). The FORT and FOI indices were calculated as ratios of follicle or oocyte yield to antral follicle count (AFC). Generalized estimating equations were used to account for clustering by patient with covariates for age, anti-Müllerian hormone (AMH), weight, stimulation duration, gonadotrophin dose and elective freeze. RESULTS: The CFA yielded the highest ovarian response indices (FORT 16-22 [61.6%], FOI-COC [106.4%], FOI-MII [81.1%]), compared with rFSH (49.3%, 98.0%, 74.6%) and HP-HMG (39.6%, 71.5%, 46.5%). Stratified analyses confirmed this ranking across AMH strata. In low AMH ( 18 follicles ≥11 mm) was lowest with CFA (6.5%), compared with 19.8% for HP-HMG and 39.2% for rFSH. CONCLUSION: After adjusting for AFC, CFA achieved the highest FORT and FOI across most AMH strata, consistently outperforming HP-HMG and matching or exceeding rFSH, while maintaining the lowest follicle-count-based OHSS risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Reproductive Medicine, Ghent University Hospital, Corneel Heymanslaan 10, 9000 Gent, Belgium; Department of Human Structure and Repair, Ghent University Faculty of Medicine and Health Sciences, Corneel Hey…
- Department of Gynecology and Obstetrics, OLV van Lourdes Hospital, Vijfseweg 150, 8790 Waregem, Belgium.
- Department of Reproductive Medicine, Ghent University Hospital, Corneel Heymanslaan 10, 9000 Gent, Belgium.
Zitieren
APA
Dhaenens, L., Rottiers, A. S., Vandierendonck, F., Hellebaut, S., Heindryckx, B., Tilleman, K., De Croo, I., De Roo, C., Vanden Meerschaut, F., & Stoop, D. (2026). Gonadotropin type and AFC-adjusted follicular recruitment and oocyte yield in 4525 antagonist cycles. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2026.105478
Vancouver
Dhaenens L, Rottiers AS, Vandierendonck F, Hellebaut S, Heindryckx B, Tilleman K, et al. Gonadotropin type and AFC-adjusted follicular recruitment and oocyte yield in 4525 antagonist cycles. Reproductive BioMedicine Online. 2026. doi:10.1016/j.rbmo.2026.105478
BibTeX
@article{Dhaenens2026,
author = {Dhaenens, Lien and Rottiers, An-Sofie and Vandierendonck, Florence and Hellebaut, Steven and Heindryckx, Björn and Tilleman, Kelly and De Croo, Ilse and De Roo, Chloë and Vanden Meerschaut, Frauke and Stoop, Dominic},
title = {Gonadotropin type and AFC-adjusted follicular recruitment and oocyte yield in 4525 antagonist cycles},
journal = {Reproductive BioMedicine Online},
year = {2026},
doi = {10.1016/j.rbmo.2026.105478}
}
EUVIMED